Biomark Diagnostics Inc. reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was CAD 0.041543 million compared to CAD 0.036889 million a year ago. Net loss was CAD 0.406761 million compared to CAD 0.393698 million a year ago.
For the nine months, sales was CAD 0.123415 million compared to CAD 0.113746 million a year ago. Net loss was CAD 1.04 million compared to CAD 1.34 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.